Survivors of breast cancer are at significantly higher risk of developing second cancers, including endometrial and ovarian cancer for women and prostate cancer for men, according to new research studying data from almost 600,000 patients in England.
Artificial intelligence can track metastatic cancer symptoms and predict drug resistance, which encourages doctors to begin effective Extinction therapy.